VALERIE ZIEMAN: Open Payments
NPI 1699211573 · FOLEY, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,855 in 103 payments from 19 companies in 2025. Trend: 2023 $1,224 · 2024 $1,764 · 2025 $1,855
Food & beverage: $1,855
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 29 | $401 |
| AstraZeneca Pharmaceuticals LP | 10 | $273 |
| Lilly USA, LLC | 10 | $174 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 7 | $165 |
| Novo Nordisk Inc | 13 | $149 |
| GlaxoSmithKline, LLC. | 6 | $108 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $99 |
| Exact Sciences Corporation | 4 | $70 |
| PFIZER INC. | 3 | $64 |
| Inspire Medical Systems, Inc. | 1 | $60 |
Products named: VRAYLAR, AIRSUPRA, CAPLYTA, MOUNJARO, Ozempic, TRELEGY ELLIPTA, Kerendia, UBRELVY.
Industry payments across AL — which companies pay providers there.
